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Abstract: A new phospholipase A2 enzyme (PLA2) has been purified from the sponge of Agelas clathroides by using 
ammonium sulphate fractionation, column chromatography and reversed-phase HPLC. It behaves as a single-band on 
SDS-PAGE with molecular weight of 39 kDa. Based on amino acids partial sequence, we cloned and sequenced
 
cDNA encoding 
PLA2.
 
It consists of 474 nucleotides encoding 157 amino acid residues including a putative initiation
 
Met. To obtain it in large 
amounts, the coding sequence of PLA2 was cloned into pGEX-2TK vector and expressed as a PLA2 fusion protein in 
Escherichia coli BL21 strain. The soluble fusion protein collected from the supernatant of the cell lysate with induction by 50 
µM isopropyl-β-D-thiogalactopyranoside (IPTG) was purified in a single-step on glutathione agarose bead chromatography. 
The purified native PLA2 protein and recombinant PLA2 fusion protein were determinated for novel antibacterial activity. 
Recombinant PLA2 fusion protein exhibited a similar antibacterial activity to the native PLA2. The recombinant PLA2 had 
stronger antibacterial activity toward Salmonella typhy and Staphylococus aureus (G
+
) with the inhibition zone diameters of 2.0 
times higher than that toward Echerichia coli and Vibrio cholerae (G
-
). These works might provide a significant foundation for 
following research on the antibacterial action of PLA2 protein from marine sponges. 
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1. Introduction 
The evolution of antibiotic-resistant bacteria has stimulated 
the search for potent antibacterial agents from natural products. 
While natural products have traditionally been harvested from 
terrestrial sources, reports showed that more than 15.000 
marine natural products have been isolated in the period from 
1965 to 2005
[1]
. A major contributing factor to this 
development is the fact that modern biotechnology has made 
easier to gain access to the great biodiversity of life found in 
the oceans
[2]
. The marine environment offers a great 
biodiversity for the isolation of pharmacologically active 
compounds
[3]
. Efficient high throughput screening methods 
have been developed to exploit the marine biodiversity 
including marine sponges (porifera) in drug discovery 
programs
[3,4]
. Since the early days of marine natural product 
discovery, Porifera (sponges) and Chordata have dominated 
as the major contributing phyla of novel bioactive 
compounds
[1]
. 
Phospholipase A2 (PLA2) catalyses the hydrolysis of the 
sn-2 acyl ester bond of phospholipids in a reaction resulting in 
the release of a free fatty acid and lysophospholipid. PLA2s 
are present as membrane-associated and soluble enzymes in 
almost all cell types and play important roles in the 
biosynthesis of eicosanoids, turnover of membrane 
phospholipids, cellular signalling and protection of 
membranes against peroxidation damage
[5]
. PLA2s are 
essential components of snake and other venoms where the 
various forms of the enzyme have haemolytic, myotoxic, 
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neurotoxic, procoagulant and anticoagulant functions
[6]
. In 
humans, PLA2s are associated with numerous clinical 
inflammatory processes
[7]
. In addition, the human and mouse 
PLA2s are highly conserved in their amino acid sequence and 
tertiary structure. An important property of secretory PLA2s is 
their capability to kill bacteria in vitro
[8]
 and in vivo
[9]
. 
The functional role of PLA2 in eicosanoid-mediated 
disorders makes this enzyme a potentially important 
therapeutic target
[10]
. The snake venom and mammalian 
PLA2s have been studied extensively and in detail; there are 
only few studies on the PLA2s of marine invertebrates
[11]
. In 
addition, distinct PLA2s have been characterised and cloned 
in a number of other animal species, including invertebrates
[12]
 
and fish
[13]
 as well as in plants
[14]
. To our knowledge, PLA2 
has not been purified and cloned from sponge, especially from 
Indonesia terrestrial such as Kapoposang island. Indonesia, 
known as a maritime country with ocean area of 75% covering 
the country, has abundant source of marine biota, among 
others are a variety of sponges species. Some species have 
been reported to contain bioactive compounds that have been 
widely applied in pharmaceutical industries
[15]
. However, 
research on the exploration of certain groups of protein 
compounds derived from sponges as a whole material for 
medicines designated to human and animal has not been 
published so far. 
In this study, we report for the first time, the purification 
and characterization of PLA2 from Agelas clathroides of 
marine sponges. Based on partial amino acid sequencing, 
cDNA encoding PLA2 was cloned and the amino acid 
sequence and structure was deduced, resulting high homology 
with cnidaria PLA2 (79%). Finally, the recombinant gene 
encoding PLA2 was expressed in E. coli BL21 strain to 
produce recombinant GST-PLA2 fusion protein and it’s 
antibacterial activity was compared with the native PLA2 
protein. The results of this work indicated that recombinant 
PLA2 had stronger antibacterial activity toward S. typhy and S. 
aureus with the inhibition zones diameters of 2.0 times higher 
than that toward the other Gram negative bacterial test. 
Regarding the two strains of Gram negative V. cholerae and E. 
coli, the inhibition zones diameters were almost the same 
using lysozyme protein as positive control. Futhermore, this 
research is the first report on the purification and gene cloning 
of a novel antibacterial PLA2 of the marine sponge. These 
works might provide a significant foundation for following 
intensive and detailed research on the structural and action of 
molecular mechanism of PLA2 protein from marine sponges 
in drug discovery programs. 
2. Materials and Methods 
2.1. Materials 
Materials used in this research were sponge Agelas 
clathroides (from Kapoposang island, South Sulawesi 
Province, Indonesia terrestrial), bacterial test of E. coli, S. 
aureus, S. typhi, and V.cholerae, aquades, MHA (Muller 
Hinton Agar) media, pGEX-2TK vector, CM-cellulose, 
Sephadex G-75, E. coli BL-21 compotent cells, Trizol reagent 
kit, buffer A (Tris-HCl 0,1 M pH 8.3, NaCl 2 M, CaCl2 0.01 
M, β - mercaptoetanol 1 %, Triton X-100 0.5 %), buffer B 
(Tris-HCl 0.1 M pH 8.3, NaCl 0.2 M, CaCl2 0.01 M), buffer C 
(Tris-HCl 0.01 M pH 8.3, NaCl 0.2 M, CaCl2 0.01 M), GST 
(Glutathion S-transferase), and lysozyme protein. 
2.2. Extraction and Isolation of Sponge PLA2 Protein 
Extraction and isolation of sponge PLA2 protein were 
conducted using previous methods as follows[16, 17], 500 g 
of fresh sample sponge Agelas clathroides, homogenized with 
waring blender in 500 mL of buffer A (Tris-HCl 0.1 M pH 8.3, 
NaCl 2 M, CaCl2 0.01 M, β -mercaptoetanol 1 %, Triton X- 
100 0.5 %), filtered with buchner. The filtrate obtained was 
freezen and thawed between 2 or 3 times, and then 
centrifugized at 12,000 rpm and 4
o
C for 30 minutes. The 
supernatant obtained was stored in a refrigerator until tested 
for antibacterial activity and further purification steps. 
2.3. Fractionation and Dialysis of Protein 
The supernatant (whole extracts) containing protein and 
having anti bacterial activities was then fractionated using 
ammonium sulphate at saturated levels of 0 – 20 %, 20 – 40 %, 
40 – 60 %, and 60 – 80 %, respectively.  
The precipitates obtained after fractionation at optimum 
saturation level of ammonium sulphate was then resuspended 
in buffer B (Tris-HCl 0.1 M pH 8.3, NaCl 0.2 M, CaCl2 0.01 
M), and then dialysed in buffer C (Tris-HCl 0,01 M pH 8.3, 
NaCl 0.2 M, CaCl2 0.01 M) using selophan pocket (Sigma) 
until colorless. After dialysis, protein fraction was subjected to 
antibacterial testing similar to the previous testing on the 
preparate of whole extract protein. 
2.4. Purification of Native PLA2 Protein 
The protein fraction of ammonium sulphate with maximum 
antibacterial activity (100 mg) of Agelas clathroides was 
dissolved in 5 mL of 50 mM Tris-HCl buffer (pH 8.3) and 
centrifuged (15,000 rpm, 5 min). The supernatant were loaded 
onto a carboxymethyl cellulose (CM, Sigma–Aldrich) 
cation-exchange column (3 X 20 cm) which had been 
equilibrated with 20 mM Tris-HCl buffer (pH 8.3). After the 
unbound proteins had been eluted, bound proteins wich 
antibacterial activity were eluted using a gradient from 20 to 
1500 mM Tris-HCl buffer (pH 8.3) at a flow rate of 0.5 
mL/min and 60 fractions were collected. Protein fractions 
were lyophilized and then redissolved in 50 mM Tris-HCl 
buffer (pH 8.3) for antibacterial activity assay. Pooled active 
fractions were loaded onto a Sephadex G-75 gel filtration 
column (1 X 30 cm, Amersham Pharmacia Biotech, Sweden). 
After the unbound proteins had been eluted, bound proteins 
wich antibacterial activity were eluted with the same buffer 
solution at a flow rate of 0.5 mL/min. The elution proteins was 
monitored at 280 nm by UV Spectrometer. The fractions were 
lyophilized and redissolved in 50 mM Tris-HCl buffer (pH 8.3) 
for antibacterial activity assay. Fractions showing antibacterial 
activity were subjected to reverse-phase high-performance 
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liquid chromatography (RP-HPLC) on a C8 column (4.6 X 
100 mm, Amersham Pharmacia Biotech, Sweden) under a 
shallower gradient from 30 to 60% acetonitrile in 0.1% TFA 
over 60 min, at a flow rate of 0.5 mL/min. The elution proteins 
was monitored at 214 nm by UV Spectrometer. After each step, 
the protein profiles of the active fractions were analyzed by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) with 10% separating gel. Proteins were detected 
by Coomassie Brilliant Blue R staining. 
2.5. Protein Concentration Quantitative 
The calculation of protein concentration at different 
purification steps was determined based on Lowry method
[18]
 
using Bovine Serum Albumine (BSA) as a standard. 
2.6. Determination of Partial Amino Acid Sequences of 
PLA2 
The purified native PLA2 (20-30 µg) was subjected to 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) with 10% separating gel. Proteins were detected 
by Coomassie Brilliant Blue R staining. A single band 
corresponding to the PLA2 protein was extracted from gel, 
and the high purity protein was treated with 
lysyl-endopeptidase enzyme in 100 µL of 50 mM Tris-HCl 
buffer (pH 8.3), at PLA2 protein ratio of 1:20 by weight for 10 
h at 30 °C. Acetonitrile was added to the reaction mixture at a 
final concentration of 5% (v/v) followed by sonication for 5 
min. The mixture was centrifuged at 15,000 rpm for 1 min at 
4°C, and the supernatant (peptides) was applied to a protein 
sequencer (Applied Biosystems Division, Model 473A, 
Perkin-Elmer). 
2.7. Preparation of the Total RNA from Sponge Agelas 
Clathroides 
The sponge Agelas clathroides was cut into small peices 
and homogenized by adding Trizol reagent (Gibco BRL) 
immediately after removal to new eppendorf tube. Total RNA 
was extracted according to the manufacturer's protocol (Gibco 
BRL). 
2.8. cDNA Synthesis and Molecular Cloning of the Gene 
Encoding PLA2 Protein 
Based on the known partial amino acid sequence and 
homogenous analysis by Protein Sequencing and BLASTN 
program
[19]
, two primers P1 and P2 were designed (P1: 
5’-CTTGCTTTGGCTGATCAAGAAAATAAG-3’, P2: 5’- 
GTTAAAATGATTCCTCATGAAACACTT-3’). RT-PCR kit 
(Takara, Japan) was used to amplify the 3′ end of cDNA, in 
which primers P1 and P2, Oligo dT-Adaptor primer M13 and 
primer M4 were used according to the manufacturer's protocol 
(Takara, Japan). After that, primer P3 
(5′-TCCCGGCCTGCAGAGACTTAGC-3′) was designed 
near the 3′ end of cDNA. RT-PCR was performed to obtain the 
encoded region of cDNA by using primer P1 and P3. Next, 
cDNA product encoding full length of PLA2 protein was 
cloning into pGEX-2TK vector to yield pGEX-2TK PLA2 
cDNA plasmid. 
2.9. cDNA Sequencing and Analysis 
The nucleotide sequence was analyzed by the dideoxy 
chain-termination method using DNA sequencer machinery 
(Applied Biosystems ABI Prism 310). The cDNA sequence 
and deduced amino acid sequence were compared with 
sequences in the GenBank database through BLASTN, 
BLASTP, and Bioedit 7.9.1 software
[19]
. 
2.10. Expression of Recombinant GST-PLA2 Fusion Protein 
in E.coli 
The GST Gene Fusion System (Pharmacia Biotech Inc.) 
was used to express PLA2 following the procedure of Ahmad, 
et al., 1999
[20].
 An overnight culture of E. coli BL21 
containing pGEX-2T PLA2 cDNA was diluted 1:10 in 400 mL 
of LB medium supplemented with 200 µg/mL ampicillin, and 
next grown at 37°C to an optical density (OD)600 of 1.0 and 
induced with 50 µM IPTG for 3 h at 37°C. The culture (400 
mL) was centrifuged and the pellet suspended
 
in 10 ml of lysis 
buffer (Tris-HCl 0.1 M pH 8.3, NaCl 2 M, CaCl2 0.01 M, β -mercaptoetanol 1 %, Triton X- 100 0.5 %), containing 
0.1% (v/v) phenylbenzosulfonyl fluoride
 
and 1 mg/mL 
lysozyme. Following a 15-min incubation on ice, 
dithiothreitol and Sarkosyl were added to 5 mM and 1.5% 
final volumes, respectively. The sample was sonicated for 2 
min on ice in a water bath sonicator, centrifuged, and Triton-X 
100 (2% final volume) was added to the supernatant. Next, 
glutathione agarose beads were added to the supernatant and 
incubated for 20 min at 4°C with gentle
 
rotation. The beads 
were collected by
 
centrifugation at 3,500 rpm for 2 min and 
washed five times with cold PBS buffer. The fusion protein 
(GST-PLA2) were eluted with 4 mL of 20 mM glutathione
 
in 
50 mM Tris-HCl pH 8.3, and the resultant eluate was 
concentrated
 
with a Millipore membrane, followed by the 
addition of glycerol
 
to a final concentration of 20%. The 
samples obtained were resolved
 
by 10% SDS-PAGE, as 
described
[20].
 The recombinant GST-PLA2 fusion protein 
concentrations were determined by Lowry method
[18] 
using 
Bovine Serum Albumine (BSA) as a standard. The 
antibacterial activity of the recombinant GST-PLA2 fusion 
protein together with the native PLA2 protein was 
determined as later described. 
2.11. Antibacterial Activity Assays 
Antibacterial activity assays against E. coli, S. aureus, S. 
typhi, and V. cholerae was conducted using diffusion method 
[16, 17]
. All about 20 µL of samples (whole extract and protein 
fractions obtained at each purification step, approximately 4 
µg), were applied on sterile paper disc (diameter 6 mm) and 
put on the agar surface of the bacterial test culture. After one 
day (24 h) incubation at 37
o
C, the inhibition zone diameter 
was determined in milimeter. The same procedure was applied 
to 20 µL GST alone (approximately 4 µg) and 20 µL lysozyme 
(approximately 4 µg) as negative and positive controls, 
respectively. The assay was conducted in duplicate and 
repeated three times to produce representative experimental 
data. 
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3. Results 
3.1. Purification of Native PLA2 Protein 
Protein fraction from ammonium sulphate fractionation was 
applied on a CM-cellulose cation-exchange column (3 X 20 
cm), and the proteins bound to the CM were eluted using a 
gradient from 20 to 1500 mM Tris-HCl pH 8.3 at a flow rate of 
0.5 ml/min and 60 fractions were collected up to 600 min. The 
fractions eluting between 0.6 and 1.2 M Tris-HCl 
demonstrated antibacterial activity (Figure 1A). The protein 
fraction from CM-Cellulose cation-exchange column that 
demonstrated antibacterial activity were applied to gel 
filtration chromatography on Sephadex-G75. Nine peaks were 
collected out of which only peak 9 showed antibacterial 
activity (Figure 1 B). For protein sequencing, peak 9 was 
further purified by reversed-phase HPLC on a C8 column 
using a shallower acetonitrile gradient, resulting in single 
protein purity (Figure 1 C). Based on SDS-PAGE (10%), the 
molecular weight of the purified PLA2 protein was estimated 
to be around 39 kDa (Figure 1 D). The result was similar to the 
one calculation based on Bioedit 7.9.1 software which showed 
that the molecular weight was 38.979 kDa (result not shown). 
 
Figure 1. Isolation and purification steps of a novel antibacterial PLA2 protein from the sponge Agelas clathroides. 
As shown in Figure 1, (A) Cation-exchange 
chromatography of protein fraction on CM-Cellulose. (B) Gel 
filtration chromatography of pooled active fractions from the 
cation-exchange column on a Sephadex G-75 column (C) Pure 
protein of peak 9 from gel filtration chromatography in (B) 
was purified by reversed-phase HPLC on a C8 column. (D) 
SDS-PAGE (10%) analysis of the active fractions obtained at 
each purification step. Lane 1, Protein marker in kDa; lane 2, 
whole extract materials; lane 3, protein fraction from 
ammonium sulphate fractionation; lane 4, pooled active 
fractions from CM cation-exchange chromatography; lane 5, 
pooled active fractions (peak 9) from gel filtration 
chromatography; lane 6, single peak from the reversed-phase 
HPLC. 
3.2. Amino Acid Sequencing and Gene Cloning Encoding 
PLA2 Protein 
At first, 11 residues amino acids (LALADQENKSL) and 
12 residues amino acids (VKCFMRNHFNNK) were 
determined by direct N-terminal amino acid sequencing of 
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PLA2 protein using Protein Sequencer. In order to obtain the 
complete amino acid sequence of the mature PLA2 protein, 
RT-PCR and cDNA sequencing were further performed. The 
primers for RT-PCR were designed based on the partial amino 
acid sequence above, and a full length cDNA fragment of 
about 541 bp, including untranslation regions was obtained. 
The fragment DNA was cloned into the pGEX-2TK vector to 
yield pGEX-2TK PLA2 cDNA plasmid (Figure 2) and than 
sequenced. The complete amino acid sequence was then 
deduced from the cDNA sequence. It shows the mature PLA2 
protein that contains an open reading frame (ORF) of 610 
nucleotides, including the untranslation regions poly A
+
 
ending and encoded 157 amino acid residues including 
initiation Met (Figure 3). Based on Bioedit 7.9.1 software, the 
amino acids sequence revealed high homology with the PLA2 
protein cnidaria (78%), but low homology with the PLA2 
protein Echinodermata (12%), and very low homology with 
the PLA2 protein chordata (6%) (Figure 4). This results 
indicated that the fragment DNA isolated from sponge Agelas 
clathroides from Kapoposang island, South Sulawesi 
Province, Indonesia was a gene encoding PLA2 protein, and 
also this gene could be amplified using the generated primer 
pairs from the partial amino acid sequence of native PLA2 
protein. Future intensive research is needed to trace the 
existence of this gene and it’s product, especially for 
determination of enzymatic activity to strengthen the 
structural and functional analysis of PLA2 protein. 
 
Figure 2. Schematic representation of the PLA2 gene synthesis by the RT-PCR 
method and the construction of pGEX-2TK fusion vector. 
As shown in Figure 2, A) Agarose gel electrophoresis of 
DNA fragment of RT-PCR product. Lane 1, DNA 
lambda/HindIII marker; lane 2, two fragments DNA 
containing pGEX-2TK vector (4963 bps) and insert of PLA2 
DNA minus 5’ untranslation region (588 bps) digested by 
NcoI/EcoRI restriction enzymes of recombinant plasmid in B; 
and lane 3, RT-PCR product of PLA2 DNA (610 bps). B) 
Restriction map of recombinant pGEX-2TK PLA2 cDNA 
plasmid. 
The nucleotide sequence was analyzed by the dideoxy 
chain-termination method. As shown in Figure 3, the result of 
N-terminal amino acid sequencing obtained from Protein 
Sequencing is indicated in box and the two primers P1 and P2 
obtained based on partial amino acids sequencing are 
underlined.  
 
Figure 3. The cDNA and deduced amino acid sequence of PLA2 protein. 
Fragment achieved by RT-PCR amplification of total sponge Agelas 
clathroides cDNAs was inserted into pGEX-2TK vector.  
The complete amino acid sequences of four proteins of 
marine invertebrate are shown in Figure 4. The positions of 
the amino acid sequence are indicated at the ends. Amino acid 
residues that are identical in two are marked with : and three 
are marked with . and analogous amino acids in all these 
proteins are indicated by bold letter. 
 
Figure 4. Comparison of the aligned amino acid sequences of PLA2 of sponge 
Agelas clathroides (ac_PLA2) with chordata (ch_PLA2), 
echinodermata(ec_PLA2), and cnidaria (cn_PLA2).  
3.3. Expression and Purification of the Recombinant PLA2 
Protein 
The coding sequence of cDNA PLA2 was expressed as part 
of the pGEX-2T fusion protein, GST-PLA2. The single-step 
purification procedure as described in Ahmad, et al., 1999 
[20]
, 
was used to improve solubility of the GST-PLA2 fusion 
protein. Based on SDS–PAGE (10%) in Figure 5, the 
molecular mass of the GST-PLA2 fusion protein product was 
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≈ 65 kDa (fusion of the molecular mass of the PLA2 alone was 
≈ 39 kDa plus the GST was ≈ 26 kDa) was dramatically 
accumulated in E.coli BL 21 cell containing the pGEX-2TK 
PLA2 plasmid with induction by 50 µM IPTG and could be 
purified to more than 95% homogeneity, using glutathione 
agarose beads (see lane 4 in Figure 5). 
 
Figure 5. Electrophoresis SDS-PAGE (10%) analysis of the recombinant 
GST-PLA2 fusion protein and native PLA2 protein. 
As shown in Figure 5, Lane 1, Protein marker; Lane 2, 
Whole extract protein in E. coli cell containing pGEX-2TK 
PLA2 cDNA; Lane 3, GST protein; Lane 4, GST-PLA2 fusion 
protein; and Lane 5, native PLA2 protein. 
3.4. Antibacterial Activity of the Recombinant GST-PLA2 
Fusion Protein 
 
Figure 6. The diameters of inhibition zone resulting from the expression of the 
native PLA2 and recombinant of GST-PLA2 fusion protein (approximately 4 
µg), negative control (GST, approximately 4 µg), and positive control 
(lysozyme, approximately 4 µg) against different bacterial strain test. 
The antibacterial activity of the recombinant GST-PLA2 
fusion protein against different bacterial tests was performed 
by agar diffusion assay. The recombinant PLA2 displayed 
antibacterial activity not only against S. typhy and S. aureus 
(Gram positive) but also against strains of E.coli and V. 
cholerae (Gram negative). The inhibitory effect of the 
recombinant PLA2 was observed towards S. typhy, S. aureus, 
V. cholerae and E.coli strains with the inhibition zone 
diameters of 24 mm, 23 mm, 13 mm, and 13 mm respectively, 
similar to native PLA2. The negative control of GST protein 
in the same concentration had no corresponding antibacterial 
activity on any of the bacterial strain test. The recombinant 
PLA2 had stronger antibacterial activity toward S. typhy and S. 
aureus with the inhibition zones diameters of 2.0 times higher 
than that toward other Gram negative bacteria. Regarding the 
two strains of Gram negative V. cholerae and E. coli the 
inhibition zones diameters were almost the same using 
lysozyme (approximately 4 µg) as positive control (Figure 6). 
4. Discussion 
In the current study, we purified and cloned a novel 
antibacterial PLA2 protein from a sponge Agelas clathroides, 
belonging to the phylum porifera. Recently Nevalainen et al. 
2004
[17]
, showed the wide distribution of PLA2 in porifera and 
it’s possible functional role in the defense system of marine 
sponges. In general PLA2, a hydrolytic enzyme, catalyzes the 
cleavage of the sn-2 acyl ester bond of phospholipases, 
resulting in the release of a free fatty acid and 
lysophospholipid. Sessile organisms like sponges are 
dependent on chemical defense and protective mechanisms 
other than active defense including migration, hiding, and 
physical attack. Depending on habitat changes, the appearance 
of a predator or pathogen, and other stress factors they are 
exposed to, sessile animals follow different strategies. The 
first-line defense against sudden stress factors is the 
transformation of inactive precursor compounds stored in the 
tissue of the affected organism, thereby yielding 
transformation products that exhibit a pronounced defensive 
activity. PLA2 is a ubiquitous defense enzyme found in snake 
and bee venoms and distributed throughout the plant and 
animal kingdom
[21]
. Recent studies suggested that varying 
levels of PLA2 were found in marine invertebrates including 
Porifera
[17]
, Cnidaria
[22]
, and Echinodermata
[12]
. It has been 
reported that the cell proliferation of marine sponges is 
mediated by PLA2 
[23]
. But purification and cloning of PLA2 
from sponge, especially from Indonesia terrestrial such as 
Kapoposang island has not been reported so far. On the other 
hand, the bactericidal activity of a full set of recombinant 
human and murine sPLA2s was tested against L. 
monocytogenes, S. aureus and E. coli
[8]
. All our preliminary 
results indicated that recombinant PLA2 protein was a 
potential antibacterial protein with possible effect on the host 
immune response. 
Many antibacterial screening studies have shown that 
Gram-positive bacteria are more sensitive than Gram-negative 
bacteria to extracts of sponges and ascidians
[24, 25]
. In fact, out 
of 777 species of sponges collected from the Caribbean Sea, 
35% had activity against Gram-positive bacteria, 15% had 
activity against Gram-negative bacteria. This is in agreement 
with our results, where sponge Agelas clathroides PLA2 
protein extracted by polar solvent (Tris-HCl buffer) tested 
showed stronger activity (active at a concentration of 0.2 
µg/µL, approximately 4 µg) against Gram-positive than 
Gram-negative bacteria strains. Further investigation should 
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be conducted to confirm whether recombinant PLA2 protein is 
really involved in invertebrates immune response mechanisms, 
emphasizing the protein's dynamic change before and after 
microbe challenge, with antibodies to the recombinant PLA2 
protein. 
5. Conclusions 
In this research, a novel antibacterial PLA2 with molecular 
weight of 39 kDa from sponge Agelas clathroides was 
characterized, and its cDNA with 474 nucleotides including 
initiation and stop codon was cloned and expressed in E. coli 
as recombinant GST-PLA2 fusion protein. Our results indicate 
that PLA2 from sponge Agelas clathroides acts primarily on 
Gram-positive bacteria. 
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